新型コロナウイルスオミクロン株に関する共同研究の成果をCell誌に発表しました！
Kimura I#, Yamasoba D#, Tamura T#, Nao N#, Suzuki T#, Oda Y#, Mitoma S#, Ito J#, Nasser H#, Zahradnik J#, Uriu K, Fujita S, Kosugi Y, Wang L, Tsuda M, Kishimoto M, Ito H, Suzuki R, Shimizu R, Begum MM, Yoshimatsu K, Kimura KT, Sasaki J, Sasaki-Tabata K, Yamamoto Y, Nagamoto T, Kanamune J, Kobiyama K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Shirakawa K, Takaori-Kondo A, Kuramochi J, Schreiber G, Ishii KJ, Hashiguchi T, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Hashiguchi T*, Ikeda T*, Saito A*, Fukuhara T*, Tanaka S*, Matsuno K*, Sato K* (*equal correspondence). Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants including BA.4 and BA.5. Cell. In press, 2022. [論文].
プレスリリース [Link]。